Ireland
--:--IST
Latest
Clinical Trials in France / NCT04816227
Recruiting Observational

Expression Profile Study of Macrophages From Patients Affected by ALS or Other Related Motor Impairments

NCT04816227 · tracked via the Priya Life Science France tracker
Phase
Observational
Started
2021-09-29
Last updated
2026-03-09

Condition(s) studied

Amyotrophic Lateral Sclerosis

Study summary

The aim of this project is to analyze the macrophage transcriptome and protein markers of Amyotrophic Lateral Sclerosis (ALS) patients compared to controls (non-affected individuals, patients with other motor impairments) and asymptomatic ALS gene carriers, to find new pathways for therapeutic targets and disease biomarkers.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Agree to participate in this research and have signed an informed consent * Be able to understand the objectives and procedures of the study * Be affiliated to French social security or equivalent * Meet one of the criteria below: (i) Be affected by Amyotrophic Lateral Sclerosis (ALS) definite, probable or possible (El Escorial criteria) sporadic SALS (no known history in the family) or familial FALS (at least one other member of the family affected), (ii) not being affected by ALS but having a close relative who has or has been diagnosed with ALS and has or is a carrier of a known mutation causing ALS and has consented to a genetic analysis, (iii) Have a motor impairment including the following pathologies: Motor neuropathy, myopathy, Myositis, Spastic paraplegia, Cram / fasciculation syndrome, Chronic inflammatory polyradiculitis, somatization disorder, Anterior spinal artery syndrome, encephalitis, myelitis, Peroneal neuropathy, cervical myelopathy with radiculopathy, spinocerebellar ataxia, Kennedy disease, Spinal atrophy, Hereditary distal motor neuropathy. (iv) be accompanying a person with ALS or other motor impairment that is followed by one of the doctors from the ALS referral center at the Pitié-Salpêtrière hospital or by a neurologist from the neurophysiology department at the Pitié-Salpêtrière hospital. Exclusion Criteria: * Be subjected to a legal protection measure (safeguard of justice, curatorship or guardianship) * Refusing to participate in the study * Whose condition, in the opinion of the doctor, is incompatible with blood draw or participation in research * Being pregnant or breastfeeding

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Département de Neurologie, Hôpital de la Pitié-Salpêtrière Paris France Recruiting

More Institut National de la Santé Et de la Recherche Médicale, France trials in France

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04816227 on ClinicalTrials.gov ↗ ← All trials in France